Swedbank AB raised its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 4.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 99,295 shares of the financial services provider's stock after buying an additional 3,790 shares during the period. Swedbank AB's holdings in CME Group were worth $26,342,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Wayfinding Financial LLC bought a new position in shares of CME Group in the first quarter valued at $25,000. Cornerstone Planning Group LLC lifted its stake in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares in the last quarter. Ransom Advisory Ltd bought a new position in shares of CME Group in the first quarter valued at $31,000. Finally, Alpine Bank Wealth Management bought a new position in shares of CME Group in the first quarter valued at $32,000. 87.75% of the stock is owned by institutional investors.
CME Group Stock Performance
Shares of CME traded down $3.47 during trading hours on Monday, hitting $258.83. The company's stock had a trading volume of 1,806,776 shares, compared to its average volume of 1,812,941. The company has a market cap of $93.28 billion, a price-to-earnings ratio of 25.06, a PEG ratio of 4.75 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50 day simple moving average of $273.13 and a two-hundred day simple moving average of $270.62. CME Group Inc. has a 52-week low of $212.38 and a 52-week high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company earned $2.56 earnings per share. On average, equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is presently 48.40%.
Insider Buying and Selling
In other news, Director William R. Shepard acquired 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the transaction, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Oppenheimer increased their target price on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a report on Thursday, July 24th. Barclays set a $298.00 target price on shares of CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Piper Sandler increased their target price on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Finally, UBS Group lowered their target price on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a report on Monday, September 8th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $260.60.
Check Out Our Latest Analysis on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.